National Immunization Technical Advisory Groups (NITAGs): Guidance for their establishment and strengthening

Vaccine

Volumn 28, Issue SUPPL. 1, 2010, Pages

  Duclos, Philippe ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Immunization; National advisory committee; Policy recommendations

Indexed keywords

ADVISORY COMMITTEE; ARTICLE; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH PROGRAM; IMMUNIZATION; INDUSTRIALIZATION; INTERNATIONAL COOPERATION; MEDICAL DECISION MAKING; NATIONAL HEALTH ORGANIZATION; ORGANIZATIONAL STRUCTURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; SUPPORT GROUP; WORLD HEALTH ORGANIZATION;

ADVISORY COMMITTEES; COMMITTEE MEMBERSHIP; COMMUNICATION; DECISION MAKING; HEALTH POLICY; IMMUNIZATION; WORLD HEALTH ORGANIZATION;

EID: 77950887799     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.027     Document Type: Article

References (48)

1. World Health Organization and UNICEF. GIVS global immunization vision and strategy 2006-2015. Geneva: World Health Organization, WHO/IVB/05.05; 2005. 〈http://www.who.int/vaccines-documents/DocsPDF05/GIVS_Final_EN.pdf〉 [accessed 05.02.2010].
2. Meeting of the immunization Strategic Advisory Group of Experts, November 2006-conclusions and recommendations. Weekly Epidemiol Rec 2007;82:1-16.
3. GAVI Alliance. [Online] Available from: URL:http://www.gavialliance.org/.
4. IFFim Supporting GAVI. [Online] Available from: URL: http://www.iff-immunisation.org/.
5. Piso B., and Wild C. Decision support in vaccination policies. Vaccine 27 (2009) 5923-5928
6. Bryson M., Duclos P., Jolly A., and Cakmak N. A Global Look at National Immunization Technical Advisory Groups. Vaccine 28 Suppl. 1 (2010) A13-A17
7. Kamiya H., and Okabe N. Leadership in immunization: the relevance to Japan of the U.S.A. experience of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP). Vaccine 27 11 (2009) 1724-1728
8. Berger P., Micallef J., Barrau K., Manuel C., and Auquier P. Vaccination anti-hépatite B: après la décision du Secrétaire d'Etat à la Santé. La Presse médicale 28 31 (1999) 1702-1706
9. Guidelines for National Interagency Coordinating Committees. Brazzaville: World Health Organization, AFRO/EPI; 1998.
10. Indian Academy of Pediatrics Committee on Immunization (IAPCOI) Consensus recommendations on immunization, 2008. Indian Pediatrics 2008;45:635-48.
11. Red Book Online; 2009. 〈http://aapredbook.aappublications.org/resources/〉 [accessed 05.02.2010].
12. Smith J.C., Snider D.E., and Pickering L.K. Immunization policy development in the United States: the role of the Advisory Committee on immunization practices. Ann Inter Med 250 (2009) 45-49
13. Salisbury D.M. Development of immunization policy and its implementation in the United Kingdom. Health Aff 24 3 (2005) 744-754
14. Ismail S., Langley J., Harris T., Warshawsky B., Desai S., and FarhangMehr M. Canada's National Advisory Committee on Immunization (NACI): evidence-based decision making on vaccines and immunization. Vaccine 28 Suppl. 1 (2010) A58-A63
15. Freed G.L. The structure and function of immunization advisory committees in Western Europe. Child Health Hum Vacc 4 4 (2008) 292-297
16. Andreae M.C., Switalski K., Abraham L., and Freed G.L. National immunization advisory committees of the World Health Organization's European Region. Vaccine 27 24 (2009) 3131-3136
17. Bryson M., Duclos P., Jolly A., and Bryson J. A systematic review of national immunization policy making processes. Vaccine 28 Suppl. 1 (2010) A6-A12
18. Leclerc C. Comprendre et construire le groupe. Chronique Sociale, Les presses de l'université Laval. Quebec, Canada; 1999.
19. Mucchielli R. La dynamique des groupes: connaissance du problème, applications pratiques Formation permanente en sciences humaines. Paris: ESF; 1992.
20. Hunt J. Core concepts of organizational behaviors. The Nature of Groups PowerPoint presentation for a course delivered at the Texas Tech University; 1999 [Chapter 9].
21. Amado G., and Guittet A. La Dynamique des communications dans les groupes (1997), Armand Colin, Paris
22. Wikipedia definition of Ex officio member; 2009. 〈http://en.wikipedia.org/wiki/Ex_officio_member〉 [accessed 05.02.2010].
23. Wikipedia definition of Liaison officer; 2009. 〈http://en.wikipedia.org/wiki/Liaison_officer〉 [accessed 05.02.2010].
24. Bertók J. Managing conflict of interest in the public service: OECD guidelines and Country Experiences (2003), Organisation for Economic Co-operation and Development (OECD) Publications, Paris
25. Lurie P., Almeida C.M., Stine N., Stine A.R., and Wolfe S.M. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA 295 16 (2006) 1921-1928
26. The UK DOH, Joint Committee on Vaccination and Immunisation, Members' Code of Practice; 2009. 〈http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_098495.pdf〉 [accessed 05.02.2010].
27. Council of Europe. Recommendation No. R (2000) 10 of the Committee of Ministers to Member states on codes of conduct for public officials; 2008. 〈http://www.coe.int/t/dghl/monitoring/greco/documents/Rec%282000%2910_EN.pdf〉 [accessed 05.02.2010].
28. Floret D. Immunization: process of elaborating guidelines and their evolution in France. Annals Pharmaceutiques Françaises 67 (2009) 219-223
29. Kimman T., Boot H., Berbers G., Vermeer-de Bondt P.E., Ardine de Wit G., and de Melker H.E. Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs. Vaccine 24 (2006) 4769-4778
30. Erickson L.J., De Wals P., and Farand L. An analytical framework for immunization programs in Canada. Vaccine 23 19 (2005) 2470-2476
31. Evidence-based recommendations for immunization-methods of the National Advisory Committee on Immunization. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2009;35(ACS-1):1-10.
32. Andrus J.K., Toscano C.M., Lewis M., Oliveira L., Ropero A.M., Dávila M., et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative. Public Health Rep 122 6 (2007) 811-816
33. Zimmerman R.K., and Jackson R.E. Vaccine policy decisions: tension between science, cost-effectiveness and consensus?. Am Fam Phys 63 10 (2001) 1919-1923
34. Morrato E.H., Elias M., and Gericke C.A. Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA. J Public Health (Oxf) 29 4 (2007) 463-471
35. Iglesias C.P., Drummond M.F., Rovira J., and NEVALAT Project Group. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care 21 1 (2005) 1-14
36. Hoffmann C., and Graf von der Schulenburg J.M. The influence of economic evaluation studies on decision making. A European survey. Health Pol 52 3 (2000) 179-192
37. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC; 2000.
38. Velasco M, Perleth M, Drummond M, Gürtner F, Jørgensen T, Jovell A, et al. Best practice in undertaking and reporting health technology assessments. Working group 4 report. Int J Technol Assess Health Care 2002;18:361-422.
39. In: Higgins J., and Green S. (Eds). Cochrane handbook for systematic reviews of interventions. Version 4.2.6. The Cochrane Library (Issue 4) (2006), John Wiley & Sons, Ltd., Chichester, UK
40. Centre for Reviews and Dissemination. Undertaking systematic review of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. York, UK: CRD; 2001.
41. Quorom Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354 (1999) 1896-1900
42. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
43. Greenhalgh T. Assessing the methodological quality of published papers. BMJ 315 (1997) 305-308
44. Hailey D. Towards transparency in health technology assessment: a checklist for HTA reports. Int J Technol Assess Health Care 19 (2003) 1-7
45. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008) 924-926
46. Petherick E.S., Villanueva E.V., Dumville J., Bryan E.J., and Dharmage S. An evaluation of methods used in health technology assessments produced for the Medical Services Advisory Committee. Med J Aust 188 8 (2008) 495
47. Duclos P., and Okwo-Bele J.M. Recommandations et politiques vaccinales mondiales: Le rôle de l'OMS. Médecine/Sciences 23 (2007) 409-416
48. SIVAC website; 2009. 〈http://www.sivacinitiative.org〉 [accessed 05.02.2010].